行情

NVTA

NVTA

Invitae
NYSE

实时行情|Nasdaq Last Sale

10.81
-0.64
-5.59%
盘后: 10.81 0 0.00% 19:59 01/21 EST
开盘
11.25
昨收
11.45
最高
11.85
最低
10.75
成交量
714.13万
成交额
--
52周最高
60.25
52周最低
10.75
市值
24.47亿
市盈率(TTM)
-4.7676
分时
5日
1月
3月
1年
5年
Huntington National Bank Buys Target Corp, Hilton Worldwide Holdings Inc, Pioneer Natural ...
Columbus, OH, based Investment company Huntington National Bank (Current Portfolio) buys Target Corp, Hilton Worldwide Holdings Inc, Pioneer Natural Resources Co, Invesco BulletShares 2021 High Yield Corporate Bon, McDonald's Corp, sells iShares Silver Tru...
GuruFocus.com · 1天前
15 Worst Stock Picks of Cathie Wood
In this article, we discuss the 15 worst stock picks of Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to the 5 Worst Stock Picks of Cathie Wood. Cathie Wood, the chief ARK Investment Management, is often hailed as the ...
Insider Monkey · 1天前
9 Latest Stock Picks of Chinese Billionaire Chen Tianqiao’s Shanda Asset Management
In this piece, we will take a look at the 9 latest stock picks of Chinese billionaire Chen Tianqiao’s Shanda Asset Management. If you want to jump ahead to the top five stocks in this list, then head on over to the 5 Latest Stock Picks of Chinese Billionai...
Insider Monkey · 2天前
Bourne Lent Asset Management Inc Buys Amgen Inc, Invitae Corp, Consolidated Edison Inc, Sells ...
Investment company Bourne Lent Asset Management Inc (Current Portfolio) buys Amgen Inc, Invitae Corp, Consolidated Edison Inc, Bank of New York Mellon Corp, sells International Business Machines Corp, The Western Union Co during the 3-months ended 2021Q4, ...
GuruFocus.com · 2天前
Invitae extends losing streak after lower-than-expected prelim. 2021 revenue
Invitae Corporation (NVTA -6.0%) is trading lower for the fifth straight session after the company reported preliminary, unaudited financial results that fell below expectations for 2021. The medical genetics company
Seekingalpha · 01/10 18:11
2 Falling Knives to Catch
Invitae Corp and GrowGeneration Corp have positive ratings despite falling more than 59% over the past year
GuruFocus.com · 01/10 17:03
Investors one-year losses grow to 75% as the stock sheds US$616m this past week
As every investor would know, you don't hit a homerun every time you swing. But it should be a priority to avoid...
Simply Wall St. · 01/10 14:12
Invitae to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 9:45 a.m. Easter...
PR Newswire · 01/05 12:30
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解NVTA最新的财务预测,通过NVTA每股收益,每股净资产,每股现金流等数据分析Invitae近期的经营情况,然后做出明智的投资选择。
分析师评级

10位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

20.00%强力推荐
30.00%买入
50.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测NVTA价格均价为32.49,最高价位44.40,最低价为25.00。
最高44.40
均价32.49
最低25.00
现价10.81
EPS
实际EPS
预期EPS
-0.73-0.55-0.36-0.18
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 429
机构持股: 2.12亿
持股比例: 93.45%
总股本: 2.26亿
类型机构数股数
增持
140
1,713.18万
建仓
52
636.77万
减持
96
455.25万
平仓
65
680.54万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-1.82%
制药与医学研究
-1.11%
高管信息
Non-Executive Chairman/Independent Director
Eric Aguiar
President/Chief Executive Officer/Co-Founder/Director
Sean George
Chief Financial Officer
Yafei Wen
Chief Operating Officer
Kenneth Knight
Chief Accounting Officer
Robert Werner
General Counsel/Secretary
Thomas Brida
Other
Robert Nussbaum
Other
Katherine Stueland
Other
Karthik Suri
Independent Director
Geoffrey Crouse
Independent Director
Christine Gorjanc
Independent Director
Kimber Lockhart
Independent Director
Chitra Nayak
暂无数据
NVTA 简况
Invitae Corp是一家医学遗传学公司。该公司致力于提供基因检测服务,支持从遗传疾病诊断到计划生育、主动健康筛查到个性化诊断、治疗和癌症监测的终生病患护理。这些测试通过为患者、医疗保健提供者、生物制药公司和其他合作伙伴提供服务的平台提供,从而捕捉遗传学的潜力并帮助扩大其在整个医疗保健领域的应用。其应用设计、过程自动化、机器人技术和生物信息学软件解决方案来提高样本处理和复杂变异解释的效率,从而实现大规模医学解释。该公司提供跨多个临床领域的基因检测,包括遗传性癌症、心脏病学、神经病学、儿科、个性化肿瘤学、代谢疾病和罕见疾病。

微牛提供Invitae Corp(NYSE-NVTA)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NVTA股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NVTA股票基本功能。